Spectral Medical

Spectral Medical Inc is a company that develops innovative technologies for disease management.In March 2009, Spectral signed a license agreement with Toray Industries, granting Spectral the exclusive development and commercial rights in the US for toraymyxin, a therapeutic device for the treatment of sepsis that removes endotoxin from the bloodstream.In October 2022, Spectral Medical Inc. had announce the launch of a proposed prospectus offering of units of the Company and private placement of convertible senior notes of at least C$8.5 million. Later that month, Spectral Medical Inc announced that further to its previously proposed prospectus offering of units of the Company and private placement of convertible senior notes, Paradigm Capital Inc has agreed to offer units at C$0.40 per Unit to raise C$8.5 million. In November 2022, Spectral Medical Inc closed its previously announced prospectus offering of units of the Company and concurrent private placement of US$5 million o